Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519272 · ClinicalTrials.gov registry record
A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00519272: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00519272 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00519272 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The goal of this behavioral research study is to look at the reasons that may prevent women from getting early treatment for their cervical cancer.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-07-21 |
| Est. Completion | 2019-05-15 |
Why NCT00519272 stopped before completion
NCT00519272 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00519272 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00519272 about?
NCT00519272 is a clinical study titled "A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients". The goal of this behavioral research study is to look at the reasons that may prevent women from getting early treatment for their cervical cancer.
What is the current status of trial NCT00519272?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2006-07-21. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT00519272?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00519272?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI